Skip to main content
SpringerLink
Log in

Progress in the management of high risk non-Hodgkin's lymphomas

10 years of experience of the 3rd medical department of hanusch hospital, Vienna

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

An analysis of 173 cases of non-Hodgkin's lymphoma (NHL) admitted to our hospital from January 1973 to January 1983 is presented. Of the 173 cases, 124 patients suffered from NHL of high grade malignancy according to the Kiel classification (37 centroblastic lymphoma (CB), 30 immunoblastic lymphoma (IB), 43 lymphoblastic lymphoma (LB), 14 NHL high grade malignancy unclassifiable). In addition, 26 patients with secondary high grade malignant NHL were included in the analysis (14 secondary CB, 10 secondary IB, 2 secondary LB). Also investigated were 23 patients with anaplastic centrocytic lymphoma (CC) (20 primary CC, 3 secondary CC), an entity originally classified as low grade malignant lymphoma, but showing a poor outcome and need for aggressive therapy. Symptoms at presentation of all patients are described. Of the 173 patients, 71% had an advanced stage of the disease at the time of diagnosis (Ann Arbor stage III or IV). B-symptoms were observed in 81%. Extranodal involvement, (exceptive bone marrow involvement), determined by clinical examination was seen in 55%. Survival of patients changed significantly after replacing initial radiotherapy with aggressive chemotherapy (P<0.001). Improvement of survival statistics was due to the better outcome of patients with localized stages (Ann Arbor stages I and II) as compared to those with generalized disease (P<0.002). Prognostic factors influencing survival were elevation of lactic dehydrogenase (P<0.0001) and response to therapy (P<0.0001). Histological subtypes according to the Kiel classification also showed prognostic relevance. The outcome of patients was significantly influenced by the therapeutic modalities administered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

CB:

Centroblastic lymphoma

CB/CC:

Centroblastic/centrocytic lymphoma

CC:

Centrocytic lymphoma large cell (Synonyma: anaplastic centrocytic lymphoma)

CHOP:

Cyclophosphamid, Adriamycin, Oncovin, Prednison

C-MOPP:

Cyclophosphamid, Oncovin, Prednison, Procarbazine

COP:

Cyclophosphamid, Oncovin, Prednison

CR:

Complete remission

CS:

Clinical stage

IB:

Immunoblastic lymphoma

LB:

Lymphoblastic lymphoma

References

  1. Anderson T, De Vita VT, Simon RM, Berard CW, Canellos GP, Garvin AJ, Young RC (1982) Malignant Lymphoma: II Prognostic Factors and Response to Treatment of 473 patients of the National Cancer Institute. Cancer 50:2708–2721

    Google Scholar 

  2. Armitage JO, Dick FR, Corder MP (1981) Diffuse histiocytic lymphoma after histologic conversion: A poor prognostic variant. Cancer Treat Rep 65:413–418

    Google Scholar 

  3. Bloomfield CD, Goldman A, Dick F, Brunning RD, Kennedy BJ (1974) Multivariant analysis of prognostic factors in the non-Hodgkin's Lymphomas. Cancer 33:870–879

    Google Scholar 

  4. Baumgartner G, Heinz R, Scharl M (E1983) New chemotherapeutic schedules in bad risk NHL. Proceedings of 13th Intern Congr of Chemotherapy, part 239:5–8

  5. Bremer K, Meusers P, Brittinger G (1980) Chemotherapie der Non-Hodgkin Lymphome. Internist 21:512–528

    Google Scholar 

  6. Brittinger G, Bartels H, Bremer K, Burger A, Dühmke E, Gunzer U, König E, Stacher A, Stein H, Theml H, Waldner R (Kieler Lymphomgruppe) (1977) Retrospektive Untersuchungen zur klinischen Bedeutung der Kiel-Klassifikation der malignen Non-Hodgkin-Lymphome. Strahlentherapie 153:228

    Google Scholar 

  7. Brittinger G, Bartels H, Common H, Dühmke E, Fülle HH, Gunzer U, Gyenes T, Heinz R, König E, Meusers P, Paukstat M, Pralle H, Theml H, Köpcke W, Thieme C, Zwingers T, Musshoff K, Stacher A, Brücher H, Herrmann F, Ludwig WD, Pribilla W, Burger-Schüler A, Löhr GW, Gremmel H, Oertel J, Gerhartz H, Koeppen KM, Boll I, Huhn D, Binder T, Schoengen A, Nowicki L, Pees HW, Scheurlen PG, Leopold H, Wannenmacher M, Schmidt M, Löffler H, Michlmayer G, Thiel E, Zettel R, Rühl U, Wilke HJ, Schwarze EW, Feller AC, Stein H, Lennert KJ (Kiel Lymphoma Study Group) (1984) Clinical and prognostic relevance of the Kiel Classification of Non-Hodgkin-Lymphomas: Results of a prospective multicenter Study by the Kiel Lymphoma Study Group. Hematological Oncology, Vol. 2, pp 269–306

    Google Scholar 

  8. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the committee on Hodgkin's diseases staging classification. Cancer Res 31:1060–1061

    Google Scholar 

  9. Ciampi A, Bush RS, Gospodarowicz M, Till JE (1981) An approach to classifying prognostic factors related to survival. Experience for non-Hodgkin's Lymphoma patients. Cancer 47:621–627

    Google Scholar 

  10. Cohen LF, Balow JE, Magrath LT, Poplack DG, Ziegler JL (1980) Acute tumor lysis syndrome. A Review of 37 patients with Burkitt's Lymphoma. Am J Med 68/4:486–491

    Google Scholar 

  11. Delbrück H, Weichert HC, Schmitt G, Firusion N, Wetter O (1978) Der Zusammenhang zwischen Prognose und Kieler-Klassifikation der malignen Non-Hodgkin Lymphome. Klin Wochenschr 56:539–543

    Google Scholar 

  12. De Vita VT, Hubbard SM (1982) The curative potential of chemotherapy in the treatment of Hodgkin's disease and Non-Hodgkin's Lymphomas. pp 280–419 in: Malignant Lymphoma (Ed.: SA Rosenberg, H.S. Kaplan) Academic Press

  13. Dixon WD, Braun MB (1981) A Biomedical computer programs BMDP-77 Univ. of California Press — Berkeley Los Angeles London

    Google Scholar 

  14. Ferraris AM, Guitini P, Gaetini GF (1979) Serum lactic dehydrogenase as a prognostic tool for non-Hodgkin-lymphomas. Blood 54:928–932

    Google Scholar 

  15. Fisher RI, Hubbard SM, De Vita VT, Berard CW, Wesly R, Cossman J, Young RC (1981) Factors predicting long-term survival in diffuse mixed histiocytic or undifferentiated lymphoma. Blood 58:45–51

    Google Scholar 

  16. Fisher RI, De Vita VT, Hubbard SM, Longo DL, Westly R, Chabner BA, Young RC (1983) Diffuse aggressive lymphoma: Increased survival after alternating flexible sequences of PROMACE and MOPP chemotherapy. Ann Int Med 98:304–309

    Google Scholar 

  17. Fleming ID, Mitchell St, Dilawari RA (1982) The Role of Surgery in the Management of Gastric Lymphoma. Cancer 49:1135–1141

    Google Scholar 

  18. Fram RJ, Skarin AT, Rosenthal DS, Pinkus G, Nadler LM (1983) Clinical, pathologic and immunological features of patients with non-Hodgkin's Lymphoma in a leukemic phase. Cancer 52:1220–1228

    Google Scholar 

  19. Freeman C, Berg JW, Cutler SJ (1972) Occurrence and prognosis of Extranodal Lymphomas. Cancer 29:252–260

    Google Scholar 

  20. Gerard-Marchant R, Hamlin I, Lennert K, Rilke F, Stanfeld AG, von Unnik JAM (1974) Classification of non-Hodgkin's Lymphomas. Lancet II:406–408

    Google Scholar 

  21. Glick JH, McFadden E, Costello W, Ezdinli E, Berard C, Bennett JM (1982) Nodular histiocytic lymphoma: Factors influencing prognosis and implications for aggressive treatment. Cancer 49:840–845

    Google Scholar 

  22. Hagberg H, Siegbahn A (1983) Prognostic Value of Serum Lactic Dehydrogenase in Non-Hodgkin's Lymphoma. Scand J Haematol 31:49–56

    Google Scholar 

  23. Hajnos G, Pirovino M, Rüthner JR (1976) Extranoduläre Manifestationen generalisierter maligner Lymphome. Schweiz med Wochenschr 106:234–239

    Google Scholar 

  24. Heinz R, Neumann E, Pont J, Schüller J, Walcher G, Hanak H, Radaszkiewicz T, Sinn E, Wirth M, Dittrich C, Schwarzmeier J, Kühböck J, Honetz N, Alth G, Stacher A (1983) Therapiestudie bei hochmalignen Non-Hodgkin Lymphomen (NHL). Verhandlungen der Dtsch Ges Inn Med 89:1010–1012

    Google Scholar 

  25. Horwich A, Peckham M (1983) “Bad Risk” Non Hodgkin Lymphomas. Semin Hematol 20:35–56

    Google Scholar 

  26. Kaplan EL, Meier P (1958) Non parametric estimation from incomplete observation. J An Statis Assn 53:457–481

    Google Scholar 

  27. König E, Bartels H, Bremer K, Burger-Schüler A, Common H, Dühmke E, Engelhardt M, Fülle HH, Gunzer U, Köppen KM, Leopold H, Nowicki L, Oertel J, Petzmann S, Rühl U, Schmidt M, Schögen A, Scholle H, Stacher A, Wolf-Hornung B, Schwarze EW, Brittinger G (Kiel Lymphoma Study Group) (1981) Germinal Center Cell Lymphomas: Prognostic significance of their histologic differentiation. Blut 43:193–200

    Google Scholar 

  28. Lennert K, Mohri N, Stein H, Kaiserling E, Müller-Hermelink H (1978) Malignant Lymphomas other than Hodgkin's Disease. Handbuch d. speziellen pathologischen Anatomie und Histologie I/3b, Springer, Berlin Heidelberg New York

    Google Scholar 

  29. Mackintosh FR, Golby ThV, Podolsky WJ, Burke JS, Hoppe RT, Rosenfelt FP, Rosenberg SA, Kaplan HS (1982) Central nervous system involvement in non-Hodgkin's Lymphoma: An analysis of 105 cases. Cancer 49:586–595

    Google Scholar 

  30. Meugé C, Hoerni B, De Mascarel A, Durand B, Richaud P, Hoerni-Simon G, Chauvergne J, Lagarde C (1973) Non-Hodgkin malignant lymphomas. Clinicopathologic correlations with the Kiel classification. Retrospective analysis of a series of 274 cases. Eur J Cancer Clin Oncol 14:587–592

    Google Scholar 

  31. Miller TP, Jones SE (1979) Chemotherapy of localized histiocytic lymphoma. Lancet I:358–360

    Google Scholar 

  32. Ostrow St, Diggs CH, Sutherland J, Wiernik PH (1981) Causes of death in patients with non-Hodgkin's lymphoma. Cancer 48:779–782

    Google Scholar 

  33. Ree HJ, Reege VP, Knisley RE, Thayer WR, D'Amico RP, Song JY, Crowley JP (1980) Malignant lymphoma of Waldeyer's ring following gastrointestinal lymphoma. Cancer 46:1528–1535

    Google Scholar 

  34. Riehm H, Gardner H, Welte K (1977) Die Westberliner Studie zur Behandlung der akuten lymphoblastischen Leukämie des Kindes — Erfahrungsbericht nach 6 Jahren. Klin Pediatr 189:89–95

    Google Scholar 

  35. Rosenberg SA (1982) The non-Hodgkin's lymphoma pathologic classification project: national cancer institute sponsered study of classifications of non-Hodgkin's lymphomas. Summary and Description of a Working Formulation for Clinical Usage. Cancer 49:2112–2135

    Google Scholar 

  36. Rudders RA, Ross ME, Delellis RA (1980) Primary extranodal lymphoma: response to treatment and factors influencing prognosis. Cancer 42:406–416

    Google Scholar 

  37. Schneider RJ, Seibert K, Passe S, Little C, Gee T, Lee BJ, Mike V, Young CW (1980) Prognostic Significance of Serum Lactate Dehydrogenase in Malignant Lymphome. Cancer 46:139–143

    Google Scholar 

  38. Shimm DS, Dosoretz DE, Anderson Th, Linggood RM, Harris NL, Wang CC (1983) Primary gastric lymphoma: an analysis with emphasis of prognostic factors and radiation therapy. Cancer 52:2044–2048

    Google Scholar 

  39. Weingrad DN, Decosse JJ, Sherlock P, Straus D, Lieberman PhH, Filippa DA (1982) Primary gastrointestinal lymphoma: A 30-year review. Cancer 49:1258–1265

    Google Scholar 

  40. Young RC, Howser DM, Anderson T, Fisher RI, Jaffe E, De Vita VT (1979) Central nervous system complications of non-Hodgkin's lymphoma: The potential role for prophylatic therapy. Am J Med 66:435–443

    Google Scholar 

  41. Ziegler JL (1977) Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience. N Engl J Med 297:75–80

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ludwig Boltzmann-Institut für Leukämieforschung und Hämatologie, III. Medizinische Abteilung, Handusch-Krankenhaus, Wien

    R. Heinz & A. Stacher

  2. Institut für Pathologie Hanusch-Krankenhaus, Wien

    H. Hanak

Authors
  1. R. Heinz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Hanak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Stacher
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heinz, R., Hanak, H. & Stacher, A. Progress in the management of high risk non-Hodgkin's lymphomas. Klin Wochenschr 63, 619–626 (1985). https://doi.org/10.1007/BF01732856

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01732856

Key words

Search

Navigation